PEER TO PEER 
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on preeclampsia from different vantage points.
Study highlights concerns about premature adoption of preeclampsia screening tests, emphasizing the need for clinical utility trials before widespread implementation.
Recent preeclampsia studies have investigated predictors such as placenta location and PAPP-A, in addition to comparing the P/C ratio with 24-hour proteinuria.
The reasons why preeclampsia and other hypertensive disorders impact up to 8% of pregnancies are not fully understood, prompting calls for further research.
Elevations in biomarkers such as uterine artery pulsatility index and placental growth factor throughout pregnancy indicate preeclampsia risk.
Findings published in Clinical Epigenetics underscore the impact of differentially methylated regions in pregnancy complications, including preeclampsia.
PW QUIZ
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
